Product logins

Find logins to all Clarivate products below.


Cecilia Klein, PhD

Director for Discovery and Translational Science Consulting

As Global Lead for Clarivate Discovery and Translational Science Consulting Services, Cecilia leads a team of consultants with in-depth knowledge in statistical and machine learning techniques, network, image and multi-OMICs data analysis. They support pharma and biotech customers in the drug discovery process through target and biomarker identification, understanding mechanisms of pathology or drug action and prioritizing candidates for drug repurposing.

Cecilia is expert at making the complex simple and actionable in a timely manner. Her focus is on helping scientists improve decision making and accelerate execution in the area of drug discovery.

Over the past 10+ years working as a computational biologist, she has dealt with virtually every flavor of NGS technologies at every stage of the experimental process: from experimental design through data acquisition to analysis, visualization and interpretation of the results.

Prior to joining Clarivate in 2019, Cecilia completed her PhD in Bioinformatics at the University of Lyon (France) and her Masters in Computational Biology at the National Laboratory of Scientific Computing (Rio de Janeiro, Brazil). She received her Bachelors Degree in Biology from the Federal University of Rio Grande do Sul. She speaks five languages: Portuguese, Spanish, French, English and Catalan. She is also learning Japanese.


arrow_forward
Get in touch with Cecilia

Latest news

News October 14, 2025
Clarivate Repeats Success in Nobel Prize Predictions with 6 New Laureates Identified by Citation Laureates Program

89 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 London, U.K. October 14, 2025: Clarivate Plc (NYSE:CLVT), a leading global provider of…

News October 7, 2025
Winbond Selects IPfolio from Clarivate

Global Electronics Manufacturer to Modernize IP Management and Drive Digital Transformation London, U.K. October 7, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that…

News October 6, 2025
Clarivate to Report Third Quarter 2025 Results on October 29, 2025

London, U.K., October 6, 2025 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the third…

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025